Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bicarbonate transporter (primary: Anion exchanger 2, secondary: Sodium bicarbonate cotransporter 1) (AE2 (for Anion exchanger 2), NBCe1 (for Sodium bicarbonate cotransporter 1))
- Target
- AE2 (for Anion exchanger 2), NBCe1 (for Sodium bicarbonate cotransporter 1)
- Molecular classification
- Transporter, Ion channel (functional role in bicarbonate and chloride movement), Enzyme complex participant (via interaction with carbonic anhydrase)
01
Overview
Bicarbonate secretion in the gastric epithelium is a physiological defense mechanism whereby surface epithelial cells transport bicarbonate ions into the mucus layer covering the stomach lining. This is primarily mediated by transporters such as anion exchanger 2 (AE2/SLC4A2) and sodium bicarbonate cotransporter 1 (NBCe1/SLC4A4). These molecules orchestrate the exchange of bicarbonate and chloride (or sodium) ions, maintaining a near-neutral pH at the epithelial surface and protecting against acid and pepsin-induced damage. Impaired bicarbonate secretion is implicated in several gastric diseases, and pharmacologic agents that modulate this pathway can have therapeutic or adverse effects.
- Other names
- SLC4A2 (AE2)SLC4A4 (NBCe1)Cl^−/HCO3^− exchangerSodium bicarbonate cotransporterBicarbonate transporter family
02
Mechanism of action
Inhibitors block ion exchange or cotransport activity, reducing bicarbonate secretion and altering local pH protection Some agents (e.g., prostaglandins, VIP) stimulate bicarbonate secretion via signaling pathways
03
Biological functions
Mucosal protectionAcid-base balanceElectrolyte transportMaintenance of juxtamucosal pH
04
Disease associations
Peptic ulcer diseaseGastritisAcid-related mucosal injuryCystic fibrosis (impaired secretion)
05
Safety considerations
Inhibition or dysfunction can lead to mucosal injury or ulceration, especially in patients receiving NSAIDs or in cystic fibrosis
06
Interacting drugs
DIDS (4,4'-diisothiocyanostilbene-2,2'-disulfonic acid, an inhibitor of Cl^−/HCO3^− exchangers)
2 more in the full profile.
07
Biomarkers
Mucosal bicarbonate secretion (functional readout)Surface pH gradient in gastric epitheliumExpression levels of SLC4/SLC26 transporters
Beyond the preview
Go deeper on Bicarbonate transporter (primary: Anion exchanger 2, secondary: Sodium bicarbonate cotransporter 1) (AE2 (for Anion exchanger 2), NBCe1 (for Sodium bicarbonate cotransporter 1)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bicarbonate transporter (primary: Anion exchanger 2, secondary: Sodium bicarbonate cotransporter 1) (AE2 (for Anion exchanger 2), NBCe1 (for Sodium bicarbonate cotransporter 1)).